非阻塞性冠状动脉在患有非St升高急性冠状动脉综合征的患者中
Shakir Zada1, Khalid Iqbal Bhatti1, Muhammad Zeb1
1National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.
Journal of Ayub Medical College, Abbottabad : JAMC
|February 26, 2024
概括
非阻塞性冠状动脉在非ST升高急性冠状动脉综合征 (NSTE-ACS) 患者中很常见. 这项研究发现,14.4%的NSTE-ACS患者有非阻塞性冠状动脉,突出显示需要进一步研究.
科学领域:
- 心脏病学 心脏病学
- 血管医学 血管医学
- 诊断成像 诊断成像 诊断成像
背景情况:
- 心血管疾病是全球死亡的主要原因之一.
- 急性冠状动脉综合征 (ACS) 是一个常见的表现,非ST升高ACS (NSTE-ACS) 占病例的70%.
- NSTE-ACS通常涉及部分或间歇性冠状动脉封闭,需要对非阻塞性原因进行调查.
研究的目的:
- 确定NSTE-ACS患者非阻塞性冠状动脉的患病率和特征.
- 在这个患者队列中调查与非阻塞性冠状动脉相关的人口和临床因素.
- 在巴基斯坦人口中为了解NSTE-ACS做出贡献.
主要方法:
- 一项描述性的横截面研究在第三级医疗保健心脏中心进行.
- 包括174名年龄在30-70岁之间的患者,他们接受了NSTE-ACS.
- 冠状动脉扫描用于识别非阻塞性冠状动脉 (缺少≥50%的狭窄).
主要成果:
- 这项研究包括174名患者 (56.9%是男性,平均年龄为59.43±11.24岁).
- 流行并发症包括高血压 (43.7%),高脂血症 (31.6%) 和慢性病 (11.5%).
- 在25名患者 (14.4%) 中发现了非阻塞性冠状动脉.
结论:
- 在这种人群中,非阻塞性冠状动脉是出现NSTE-ACS的患者的重要发现.
- 14.4%的患病率强调了在NSTE-ACS中考虑非阻塞性原因的重要性.
- 建议在NSTE-ACS中进行进一步的研究,以阐明病理生理学,并优化对非阻塞性冠状动脉疾病 (NOCA) 的管理.
相关概念视频
01:17Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
01:17Imaging Studies for Cardiovascular System I:Echocardiography
331
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
331
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
513
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
513
01:16Antianginal Drugs: Nitrates and β-Blockers
590
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
590